Moderna is a pioneer in using mRNA technology, first with the Covid vaccine. Its flu shot was being developed for people 50 and older.
2026-02-10 1204词 困难
0:00
0:00
此音频仅限会员使用成为会员
Moderna had spent years and hundreds of millions of dollars testing its flu vaccine, enrolling 41,000 people and aimed at a market of adults ages 50 and older. The company concluded that its shot was superior to GSK’s product.
免责声明：本文来自网络公开资料，仅供学习交流，其观点和倾向不代表本站立场。